Information on the Target

Since its establishment in 2013 and based in Indianapolis, Paradigm Health has emerged as a prominent provider of hospice and palliative care services. The Company operates six branches throughout Indiana, offering holistic and patient-centered care. By taking an innovative, community-based approach, Paradigm collaborates closely with patients' healthcare providers to create personalized care plans aimed at improving the quality of life for patients and their families. These services are delivered in various settings, including homes and long-term care facilities.

With its dedication to compassionate care, Paradigm is poised for further growth. The partnership with Cressey & Company LP, along with continued support from existing investor Havencrest Capital Management, aims to enhance the Company's capacity to serve a larger patient base while maintaining its high standards of care.

Industry Overview in Indiana

The hospice and palliative care industry in Indiana has been experiencing significant growth, fueled by an increasing aging population and a rising demand for healthcare services tailored to end-of-life needs. As more families seek quality care for loved ones in their final stages of life, providers like Paradigm play a crucial role in meeting these evolving demands.

Indiana's healthcare landscape is characterized by a blend of nonprofit and for-profit providers, fostering a competitive environment that encourages innovation and enhanced patient services. Providers that focus on quality and patient satisfaction, such as Paradigm, are increasingly recognized for their ability to deliver effective and compassionate care.

According to industry reports, the hospices in Indiana are also adapting to regulatory changes and funding models, which presents both challenges and opportunities for growth. A growing emphasis on community-based care aligns with Paradigm’s mission and strategic positioning within the state, suggesting that continued investment in this sector will yield positive outcomes.

The trend towards integrated care models, wherein various health care services are coordinated across providers, is expected to further influence the hospice industry. Paradigm's innovative approach places it at the forefront of this evolution, enhancing its potential for expansion and increased market share in the coming years.

The Rationale Behind the Deal

The partnership between Cressey & Company and Paradigm is driven by a shared vision of improving patient outcomes in hospice and palliative care. Cressey brings valuable resources and strategic insights, which are critical as Paradigm prepares for larger-scale operations. The collaboration aims to help Paradigm extend its reach while concentrating on quality care and innovation.

This investment represents a timely opportunity to capitalize on the expanding demand for hospice services in Indiana, particularly as families increasingly prioritize compassionate care for their loved ones. Cressey’s proven experience in nurturing healthcare businesses reinforces the potential for successful growth and improved service delivery through this partnership.

Information About the Investor

Cressey & Company LP is a private investment firm dedicated to building influential businesses in the healthcare services and information technology sectors. With a strong track record of investing in post-acute services, the firm is well-positioned to support companies like Paradigm that are committed to enhancing healthcare quality.

Under the leadership of skilled partners, Cressey aims to foster corporate growth through active collaboration with their portfolio companies, utilizing both financial investment and strategic insight. Their commitment to clinical excellence and innovation aligns seamlessly with Paradigm's mission, making them an ideal partner for advancing compassionate care in hospice and palliative settings.

View of Dealert

This partnership stands as a promising investment from both a strategic and ethical perspective. Cressey's investment in Paradigm provides the necessary capital and expertise to help scale operations, which is critical given the industry's growth potential. The quantified demand for enhanced hospice services, combined with Paradigm's mission-driven approach, creates a robust case for investment.

Paradigm is distinguished by its patient-centered model and commitment to quality, which are essential underpinnings for success in the healthcare industry. Given the growing market for effective hospice care solutions, the opportunity for Paradigm to evolve significantly under Cressey's guidance appears favorable.

Furthermore, the continuous support from Havencrest Capital Management reinforces confidence in Paradigm’s leadership and operations. Their commitment suggests a strong belief in Paradigm's potential for substantial growth and contribution to the community's healthcare needs.

In conclusion, the agreement between Cressey & Company and Paradigm Health is likely to represent a successful and beneficial collaboration—yielding high-quality care for patients while offering an attractive investment opportunity for stakeholders involved.

View Original Article

Similar Deals

Welsh, Carson, Anderson & Stowe Constitution Surgery Alliance

2025

Strategic Partnership Healthcare Providers & Services United States of America
Salt Creek Capital Real Diagnostics

2025

Strategic Partnership Healthcare Providers & Services United States of America
Eir Partners and New Mountain Capital Smarter Technologies

2025

Strategic Partnership Healthcare Providers & Services United States of America
Senseonics Holdings, Inc. Ascensia Diabetes Care

2025

Strategic Partnership Healthcare Providers & Services United States of America
Angeles Equity Partners, LLC and Kain Capital LLC Agile Occupational Medicine and Akeso Occupational Health

2025

Strategic Partnership Healthcare Providers & Services United States of America
Canyon Labs iuvo BioScience

2025

Strategic Partnership Healthcare Providers & Services United States of America
KKR & Co. Inc. HealthCare Royalty Partners

2025

Strategic Partnership Healthcare Providers & Services United States of America
Topcon Healthcare, Inc. Pangaea Data

2025

Strategic Partnership Healthcare Providers & Services United States of America
Maxor National Pharmacy Services ProxsysRx

2025

Strategic Partnership Healthcare Providers & Services United States of America
Princeton Equity Group Barry's

2025

Strategic Partnership Healthcare Providers & Services United States of America

Cressey & Company LP

invested in

Paradigm Health

in 2025

in a Strategic Partnership deal

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert